A critical breakthrough in cancer research is arising with the use of nanobodies to reactivate mutated p53. This crucial cancer protector protein is frequently disabled in many types of malignancies, leading https://cruxbookmarks.com/story22037791/mini-antibodies-revive-p53-new-potential-hope-for-cancer-treatment